Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine ± dexamethasone erector spinae plane block in thoracoscopic lobectomy
ChiCTR2400087769Phase 4Not yet recruiting
- Sponsor
- Yibin Second People's Hospital
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in lung neoplasm comparing ropivacaine + dexamethasone ESP block with Control: ropivacaine ESP block (2 arms). Primary endpoint: Incidence of chronic pain. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
ropivacainedexamethasone
03
Conditions
lung neoplasm
Beyond the preview
Go deeper on ChiCTR2400087769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087769.